Fondo Italiano FIPEC co-invests in Adler Ortho in Andera-led private equity deal

PUBT · 1d ago
Fondo Italiano FIPEC co-invests in Adler Ortho in Andera-led private equity deal
  • Fondo Italiano’s FIPEC co-investment fund took equity stakes in Adler Ortho, Costa Edutainment, Genetic, DMX Pharma in private financing rounds.
  • Adler Ortho designs and makes orthopedic implants, including 3D-printed surgical products; 2025 revenue about EUR 70 million with roughly 60% overseas.
  • Costa Edutainment runs Italy’s largest edutainment platform, including aquariums and theme assets; 2025 revenue about EUR 78 million on 3 million visitors.
  • Genetic is a CDMO for generic drugs focused on respiratory and ophthalmic products; 2025 revenue about EUR 130 million with over 43% abroad.
  • DMX Pharma is a 2024 CDMO merger of Mipharm and Doppel; 2025 revenue about EUR 164 million with about 40% from exports.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fondo Italiano d'Investimento SGR S.p.A. published the original content used to generate this news brief on July 27, 2026, and is solely responsible for the information contained therein.